RNA-Seq Blog Transcriptome Research & Industry News
Genetron Health announced the release of two research results from its Seq-MRD® and FusionScan Plus product studies at the Association for Molecular Pathology 2021 annual meeting. Seq-MRD® detects minimal residual disease (MRD) in B-lymphoid malignancies, while FusionScan Plus can simultaneously detect a wide ...
Read More »Two cancer research studies demonstrate use of RNA sequencing for precision oncology
